Literature DB >> 4151697

Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.

H M Beumer.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4151697     DOI： 10.2165/00003495-197407010-00009

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  28 in total

1.  The bronchoconstrictor action of propranolol aerosol in asthmatic subjects.

Authors:  I Langer
Journal:  J Physiol       Date:  1967-05       Impact factor: 5.182

2.  [Effect of various beta-receptor blockaders on ventilation in patients with obstructive respiratory tract disease. Comparative studies].

Authors:  R Wettengel; H Fabel
Journal:  Dtsch Med Wochenschr       Date:  1970-09-04       Impact factor: 0.628

3.  The effect of oxprenolol on airwy resistance.

Authors:  G M Clarke; A G Macdonald
Journal:  Postgrad Med J       Date:  1970-11       Impact factor: 2.401

4.  Risk with -blocking in bronchial asthma.

Authors:  J Gaddie; C Skinner
Journal:  Br Med J       Date:  1972-03-18

5.  -Adrenergic blockade with practolol in acetylcholine-sensitive asthma patients.

Authors:  V Nicolaescu; M Manicatide; V Stroescu
Journal:  Respiration       Date:  1972       Impact factor: 3.580

6.  [Effect of beta-adrenergic blockaders in bronchial asthma].

Authors:  H M Beumer; H J Hardonk
Journal:  Med Klin       Date:  1971-12-24

7.  Selective blockade of adrenoceptive beta receptors in the heart.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol Chemother       Date:  1968-01

8.  Practolol treatment in asthmatics.

Authors:  H J Waal-Manning; F O Simpson
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

9.  Comparison of the effect of alprenolol and propranolol on specific airway conductance in asthmatic subjects.

Authors:  C K Connolly; J C Batten
Journal:  Br Med J       Date:  1970-05-30

10.  Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects.

Authors:  P S Richardson; G M Sterling
Journal:  Br Med J       Date:  1969-07-19
View more
  15 in total

1.  Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs.

Authors:  B N Prichard
Journal:  Proc R Soc Med       Date:  1977

Review 2.  Intrinsic sympathomimetic activity of beta-adrenoceptor blocking agents.

Authors:  G Cocco; F Burkart; D Chu; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

Review 3.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

Review 4.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

5.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

6.  The effect of metoprolol and practolol on lung function and blood pressure in hypertensive asthmatics.

Authors:  H Formgren
Journal:  Br J Clin Pharmacol       Date:  1976-12       Impact factor: 4.335

7.  Use of beta-adrenoreceptor blockers in combination with beta-stimulators in patients with obstructive lung disease.

Authors:  G Johnsson
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients.

Authors:  C C Christensen; N P Boye; H Erikson; G Hansen
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

9.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

10.  Soft drugs. XX. Design, synthesis, and evaluation of ultra-short acting beta-blockers.

Authors:  H S Yang; W M Wu; N Bodor
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.